TxCell
Biotechnology ResearchFrance2-10 Employees
TxCell is now a subsidiary of Sangamo Therapeutics, Inc. and has been renamed Sangamo Therapeutics France.
TxCell uses 8 technology products and services including Creatio, Postman, Microsoft Visio, and more. Explore TxCell's tech stack below.
| TxCell Email Formats | Percentage |
| First.Last@txcell.com | 62% |
| Last@txcell.com | 38% |
| FLast@linkedin.com | 80% |
| FiLast@linkedin.com | 12% |
| LastFir@linkedin.com | 4% |
| FirLast@linkedin.com | 4% |
Biotechnology ResearchFrance2-10 Employees
TxCell is now a subsidiary of Sangamo Therapeutics, Inc. and has been renamed Sangamo Therapeutics France.
TxCell's revenue is estimated to be in the range of $1M
TxCell's revenue is estimated to be in the range of $1M